Next report date
Report period
H2 2024
EPS estimate
—
Revenue estimate
—
−0.134AUD
−34.61 MAUD
292.36 KAUD
293.82 M
About RADIOPHARM THERANOSTICS LIMITED
Sector
Industry
CEO
Riccardo Canevari
Website
Headquarters
Carlton
Founded
2021
ISIN
AU0000181851
FIGI
BBG0132XC5K0
Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is headquartered Carlton, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RAD is 0.046 AUD — it has increased by 2.22% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange RADIOPHARM THERANOSTICS LIMITED stocks are traded under the ticker RAD.
RADIOPHARM THERANOSTICS LIMITED is going to release the next earnings report on Sep 26, 2024. Keep track of upcoming events with our Earnings Calendar.
RAD stock is 11.11% volatile and has beta coefficient of −0.77. Check out the list of the most volatile stocks — is RADIOPHARM THERANOSTICS LIMITED there?
Yes, you can track RADIOPHARM THERANOSTICS LIMITED financials in yearly and quarterly reports right on TradingView.
RAD stock has risen by 2.22% compared to the previous week, the month change is a 19.30% fall, over the last year RADIOPHARM THERANOSTICS LIMITED has showed a 74.22% decrease.
RAD net income for the last quarter is −24.76 M AUD, while the quarter before that showed −22.06 M AUD of net income which accounts for −12.24% change. Track more RADIOPHARM THERANOSTICS LIMITED financial stats to get the full picture.
Today RADIOPHARM THERANOSTICS LIMITED has the market capitalization of 20.33 M, it has decreased by 2.22% over the last week.
No, RAD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RAD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RADIOPHARM THERANOSTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RADIOPHARM THERANOSTICS LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RADIOPHARM THERANOSTICS LIMITED stock shows the sell signal. See more of RADIOPHARM THERANOSTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RADIOPHARM THERANOSTICS LIMITED EBITDA is −41.11 M AUD, and current EBITDA margin is −12.65 K%. See more stats in RADIOPHARM THERANOSTICS LIMITED financial statements.